9999999997-17-005432.txt : 20170410 9999999997-17-005432.hdr.sgml : 20170410 20170410123722 ACCESSION NUMBER: 9999999997-17-005432 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170410 DATE AS OF CHANGE: 20170410 20170410 20170410 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 17752556 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9143477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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